Drug intelligence / Profile preview

rehmannia glutinosa oligosaccharide

Development stage
Preclinical
Modality
Microbiome-Derived Products → Microbiome Therapeutics
Administration
Intraperitoneal, Oral
01

Overview

Rehmannia glutinosa oligosaccharide (RGO) is a natural oligosaccharide derived from the traditional Chinese medicine herb *Rehmannia glutinosa*. It is prepared through water extraction, decolorization, impurity removal, purification, and drying. RGO has demonstrated protective effects against lipopolysaccharide (LPS)-induced intestinal inflammation and barrier injury, showing anti-inflammatory and antioxidant properties. It also exhibits hypoglycemic effects in hyperglycemic and diabetic models and promotes the differentiation of bone marrow mesenchymal stem cells into cardiomyocyte-like cells. Furthermore, RGO can enhance the viability and proliferative capacity of human adipose-derived mesenchymal stem cells and alleviate H2O2-induced apoptosis, potentially by upregulating Vascular endothelial growth factor (VEGF) and Hepatocyte growth factor (HGF). Its mechanisms involve modulating gut microbiota composition, enhancing intestinal barrier-related proteins, and influencing various inflammatory and antioxidant markers.

Other names
RGOROS生地低聚糖
02

Targets

Misfolded SOD1G6PC1 (Glucose 6-phosphatase alpha)IL-6 (Interleukin 6)NeuraminidaseVEGFA (Vascular endothelial growth factor A)TNFA (Tumor necrosis factor alpha (soluble))TJP1 (Tight junction protein 1 (ZO-1))HGF (Hepatocyte growth factor)IL-17A (Interleukin-17A)GPX4 (Glutathione peroxidase 4)IL1B (Interleukin-1 beta)OCLN (Occludin)

Beyond the preview

Go deeper on rehmannia glutinosa oligosaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rehmannia glutinosa oligosaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call